Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 81, Issue 2, pp 124–127 | Cite as

Effect of L-dopa on emotional responses and serotonin metabolism in the rat brain

  • L. Kh. Allikmet-s
  • A. M. Zharkovskii
Physiology
  • 13 Downloads

Abstract

Experiments on male Wistar rats showed that injection of L-dopa in doses of 100–200 mg/kg causes a parallel increase in the dopamine and homovanillic acid concentrations in the brain, elevation of the 5-hydroxyindoleacetic acid level, and a decrease in the serotonin concentration. Increased emotional reactivity and aggressiveness of the animals was observed at the same time. L-dopa (100 mg/kg) reduced the binding of serotonin formed from tryptophan (100 mg/kg) and accelerated its catabolism in the brain. At the same time, L-dopa abolished the depressant effect of tryptophan on emotional reactivity and aggressiveness. It is suggested that inhibition of the serotoninergic system in the brain is an essential component of the mechanism of strengthening of emotional responses under the influence of L-dopa.

Key Words

L-dopa emotional responses serotonin metabolism rat brain 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    L. Kh. Allikmet-s Zh. Vyssh. Nerv. Deyat., No. 3, 597 (1972).Google Scholar
  2. 2.
    L. Kh. Allikmet-s, Zh. Vyssh. Nerv. Deyat., No. 2, 164 (1975).Google Scholar
  3. 3.
    L. Kh. Allikmet-s and A. M. Zharkovskii, in: Problems in Pharmacology of Neurotropic Drugs [in Russian], Riga (1974), pp. 3–7.Google Scholar
  4. 4.
    S. Algeri and C. Cerletti, Europ. J. Pharmacol.,27, 191 (1974).Google Scholar
  5. 5.
    L. Kh. Allikmet-s (L. H. Allikmets), Med. Biol.,52, 19 (1974).Google Scholar
  6. 6.
    O. Benkert, H. Gluba, and N. Matussek, Neuropharmacology,12, 177 (1973).Google Scholar
  7. 7.
    L. L. Butcher and A. P. Dietrich, Naunyn-Schmiedebergs Arch. Pharmak.,277, 61 (1973).Google Scholar
  8. 8.
    B. Eichelmann, in: Chemical Approaches to Brain Function (ed. by S. Ehrenpreis and I. Kopkin), New York (1973), p. 109.Google Scholar
  9. 9.
    G. Curzon and A. R. Green, Brit. J. Pharmacol.,39, 653 (1970).Google Scholar
  10. 10.
    J. A. Harvey and L. M. Yunger, in: Serotonin and Behavior (ed. by J. Barchas and E. Usdin), New York (1973), p. 179.Google Scholar
  11. 11.
    M. Karobath, J. L. Diaz, and M. Huttunen, Biochem. Pharmacol.,21, 1243 (1972).Google Scholar
  12. 12.
    E. Lucke, K. Modigh, and B.-E. Roos, Experimentia,25, 951 (1969).Google Scholar
  13. 13.
    W. C. McLain and B. T. Cole, Pharmacol. Biochem. Behav.,2, 123 (1974).Google Scholar
  14. 14.
    L. Ng, R. W. Colburn, and I. J. Kopin, J. Pharmacol. Exp. Ther.,183, 316 (1972).Google Scholar
  15. 15.
    M. K. Shellenberger and J. H. Gordon, Analyt. Biochem.,39, 356 (1971).Google Scholar
  16. 16.
    P. F. Spano and N. H. Neff, Analyt. Biochem.,42, 113 (1971).Google Scholar
  17. 17.
    L. Valzelli, Advances Pharmacol.,5, 79 (1967).Google Scholar
  18. 18.
    A. Weissman and C. A. Harbert, Ann. Rep. Med. Chem.,7, 47 (1972).Google Scholar

Copyright information

© Plenum Publishing Corporation 1976

Authors and Affiliations

  • L. Kh. Allikmet-s
  • A. M. Zharkovskii

There are no affiliations available

Personalised recommendations